| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.84B | 30.55B | 29.22B | 28.45B | 22.24B | 19.91B |
| Gross Profit | 13.62B | 13.73B | 12.07B | 11.89B | 8.70B | 7.16B |
| EBITDA | 6.87B | 7.05B | 5.94B | 6.02B | 3.58B | 3.39B |
| Net Income | 3.96B | 3.81B | 3.13B | 4.00B | 1.99B | 2.32B |
Balance Sheet | ||||||
| Total Assets | 40.83B | 42.40B | 42.04B | 41.60B | 39.00B | 35.63B |
| Cash, Cash Equivalents and Short-Term Investments | 12.62B | 13.89B | 14.31B | 16.14B | 14.44B | 12.58B |
| Total Debt | 708.06M | 586.07M | 1.13B | 1.41B | 731.80M | 602.95M |
| Total Liabilities | 8.35B | 8.89B | 9.57B | 10.09B | 8.71B | 6.80B |
| Stockholders Equity | 31.68B | 32.74B | 31.85B | 31.09B | 30.02B | 28.67B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.95B | 1.61B | 4.49B | 2.87B | 3.10B |
| Operating Cash Flow | 0.00 | 3.94B | 2.40B | 4.85B | 3.77B | 3.59B |
| Investing Cash Flow | 0.00 | 1.47B | -2.97B | 281.92M | -1.47B | -275.41M |
| Financing Cash Flow | 0.00 | -4.71B | -4.08B | -3.71B | -1.65B | -1.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥70.13B | 9.50 | ― | 2.63% | -6.00% | -13.74% | |
75 Outperform | ¥65.74B | 13.24 | ― | 3.95% | -1.67% | -4.39% | |
74 Outperform | ¥60.34B | 24.26 | ― | 2.54% | 2.00% | 39.80% | |
72 Outperform | ¥43.45B | 12.91 | ― | 3.95% | 1.72% | 101.76% | |
67 Neutral | ¥7.62B | 3.03 | ― | 1.37% | -3.05% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥31.44B | 4.17 | ― | 2.13% | 1.13% | -66.14% |